Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,352.75
-22.85 (-1.66%)
At close: Jul 31, 2026
Eris Lifesciences Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Eris Lifesciences stock has a consensus rating of "Strong Buy" and an average price target of ₹1,661. The average 1-year stock price forecast is 22.80% higher than the current stock price, while the lowest is ₹1,435 (+6.08%) and the highest is ₹1,780 (+31.58%).
Price Target: ₹1,661 (+22.80%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eris Lifesciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Financial Forecast
Revenue This Year
35.30B
from 31.15B
Increased by 13.34%
Revenue Next Year
40.36B
from 35.30B
Increased by 14.32%
EPS This Year
42.43
from 46.52
Decreased by -8.78%
EPS Next Year
57.24
from 42.43
Increased by 34.90%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.